The serological tumor marker tissue polypeptide antigen (TPA) and the more recently identified tissue-specific polypeptide antigen (TPS) have been reported to be indicators of the proliferation rate of the tumor. In the present investigation we compared the cytosol level of the two markers with the proliferative activity of the tumor measured using the 3H-thymidine labelling index. The preliminary results presented here show that higher TLI is associated with lower cytosol levels of both TPA and TPS. TPA and TPS in the cytosol were significantly associated. These findings are in agreement with the previously demonstrated association between high TPA cytosol levels and better prognosis in breast cancer. Further studies are ongoing in order to:
1. confirm these findings in a larger patient series;
2. investigate any possible prognostic indication provided by TPS;
3. evaluate any possible biological meaning of the negative association between TPA/ TPS and TLI in the cytosol of breast cancer.
BjörklundB., BjörklundV., WiklundB.A human tissue polypeptide related to cancer and placenta: I. Preparation and properties; II. Assay technique; and III. Clinical studies of 1483 individuals with cancer and other conditions. In: Immunological techniques for detection of cancer - The Folksam Symposium.Stockholm, Sweden: Bonniers, 1973; 133–87.
WiklundB.Lüning B, Björklund B. Chemical studies of tissue polypeptide antigen (TPA). III. On the nature of the antigenic determinant(s) of TPA subfraction B1.Acta Chem Scand B1981; 35: 325–36.
4.
BjörklundB., BjörklundV.Specificity and basis of the tissue polypeptide antigen.Cancer Detect Prevent1983; 6: 41–50.
5.
NathrathW.B.J., HeidenkummerP., BjörklundB.Distribution of tissue polypeptide antigen (TPA) in normal human tissues: Immunohistochemical study on unfixed, methanol-, ethanol-, and formalin-fixed tissues.J Histochem Cytochem1985; 33(2): 99–109.
6.
WeberK., OsbornM., MollR., WiklundB., LüningB.Tissue polypeptide antigen (TPA) is related to the non-epidermal keratins 8, 18 and 19 typical of simple and non-squamous epithelia: re-evaluation of a human tumor marker.Embo J1984; 3: 2707–14.
7.
MellerickD.M., OsbornM., WeberK.On the nature of serological tissue polypeptide antigen (TPA); monoclonal keratin 8, 18 and 19 antibodies react differently with TPA prepared from human cultured carcinoma cells and TPA in human serum.Oncogene1990; 5: 1007–17.
8.
BjörklundB., BjörklundV., BrunkenerM., GrönlindH., BackM.The enigma of a human tumor marker: TPA revisited. In: Cimino, Birkmayer, Klavins, Pimentel, Salvatore, eds. Human tumor markers.Berlin: Walter de Gruyter & Co., 1987; 169–80.
9.
NemotoT., CostantineR., ChuT.M.Human tissue polypeptide antigen in breast cancer.J Natl Cane Inst1979; 63: 1347–50.
10.
BjörklundB.On the nature and clinical use of tissue polypeptide antigen (TPA).Tumor Diagnostik1980; 1: 9–20.
11.
LüthgensM., SchlegelG.CEA + TPA in der klinischen Tumordiagnostik, insbesondere des Mamma-Karzinoms.Tumor Diagnostik1980; 2S: 63–77.
12.
OehrP., BönnenU., WinklerC.Prognostic values of TPA, CEA and their combination by product formation in different cancer locations. In: PeetersH., ed. Protides Biological Fluids.Oxford: Pergamon Press, 1985.
13.
MontinariF., PanceraG., MerrinoM.Long-term follow-up and therapy monitoring of cancer: Is the simultaneous dosage of CEA and TPA useful? In: Cimino, Birkmayer, Klavins, Pimentel, Salvatore, eds. Human tumor markers.Berlin: Walter de Gruyter & Co., 1987; 613–9.
14.
GionM., MioneR., GattiC.Is tissue polypeptide antigen still a useful tumor marker in breast carcinoma? Comparison with CA15.3 and MCA.Tumori1990; 76: 360–4.
15.
BjörklundV., BjörklundB., WittekindC., von KleistS.Immuno-histochemical localization of tissue polypeptide antigen (TPA) and carcino-embryonic antigen (CEA) in breast cancer. A comparative study.Acta Path Microbiol Immunol Scand Sect A1982; 90: 471–6.
16.
GionM., MioneR., DittadiR., FasanS., PalliniA., BruscagninG.Carcinoembryonic antigen, ferritin and tissue polypeptide antigen in serum and tissue. Relationship with the receptor content in breast carcinoma.Cancer1986; 57(5): 917–22.
17.
GionM., MioneR., GattiC.Tissue polypeptide antigen in tumor cytosol: a new prognostic indicator in primary breast cancer.Breast Cancer Res Treat1990; 17: 15–21.
18.
GionM., MioneR., PappagalloG.L.Tissue polypeptide antigen in breast cancer cytosol. A new effective prognostic indicator.Eur J Cancer1993; 29A(1): 66–9.
19.
BjörklundB.Tumor markers TPA, TPA-S and cytokeratins. A working hypothesis.Tumordiagn u Ther1992; 13: 78–80.
20.
ValentiG., AmorosoD., BoccardoF., BarbettiV., TorreG.C.Correlation between serum TPS levels and tumor labelling index (TLI) in breast cancer patients.Procedings of the 9th International Conference on Human Tumor Makers. Vienna (Austria), September 6–9, 1992.
21.
EORTC Breast Cancer Cooperative Group.Revision of the standards for the assessment of hormone receptors in human breast cancer.Eur J Cancer Clin Oncol1980; 16: 1513–5.
22.
BradfordM.M.A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.Analytical Biochem1976; 72: 248–54.
23.
TubianaM., PejovicM.J., RenaudA.Kinetic parameters and the course of the disease in breast cancer.Cancer1981; 47: 937–43.
24.
SilvestriniR., DaidoneM.G., GaspariniG.Cell kinetics as a prognostic marker in node-negative breast cancer.Cancer1985; 56: 1982–7.
25.
AaltomaaS., LipponenP., EskelinenM.Mitotic indexes as prognostic predictors in female breast cancer.J Cancer Res Clin Oncol1992; 118: 75–81.
26.
RemvikosY., VielhP., PadoyE., BenyahiaB., VoillemotN., MagdelénatH.Breast cancer proliferation measured on cytological samples: a study by flow cytometry of S-phase fractions and BrdU incorporation.Br J Cancer1991; 64: 501–7.
27.
KamelO.W., FranklinW.A., RingusJ.C., MeyerJ.S.Thymidine labeling index and Ki-67 growth fraction in lesions of the breast.Am J Pathol1989; 134: 107–13.
28.
VielhP., ChevillardS., MosseriV., DonatiniB., MagdelenatH.Ki-67 index and S-phase fraction in human breast carcinomas. Comparison and correlations with prognostic factors.Am J Clin Pathol1990; 94: 681–6.
29.
LeonardiE., GirlandoS., SerioG.PCNA and Ki67 expression in breast carcinoma: correlations with clinical and biological variables.J Clin Pathol1992; 45: 416–9.
30.
FernöM., BaldetorpB., BorgÅ, OlssonH., SigurdssonH., KillanderD.Flow cytometric DNA index and S-phase fraction in breast cancer in relation to other prognostic variables and to clinical outcome.Acta Oncol1992; 31: 157–65.
31.
KallioniemiO.P., VisakorpiT., HolliK., HeikkinenA., IsolaJ., KoivulaT.Improved prognostic impact of S-phase values from paraffin-embedded breast and prostate carcinomas after correcting nuclear slicing.Cytometry1991; 12: 413–21.
32.
EwersS-B, AttewellR., BaldetorpB.Prognostic significance of flow cytometric DNA analysis and estrogen receptor content in breast carcinomas - a 10 year survival study.Breast Cancer Res Treat1992; 24: 115–26.
